Trials / Completed
CompletedNCT00490399
Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas
A Phase II Trial of GEMZAR Combined With Cisplatin in Patients With Inoperable Biliary Tract Carcinomas
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of gemcitabine and cisplatin in Korean patients with biliary tract (bile tracts of the gallbladder or liver) cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gemcitabine | |
| DRUG | cisplatin |
Timeline
- Start date
- 2003-03-01
- Completion
- 2004-09-01
- First posted
- 2007-06-22
- Last updated
- 2007-06-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00490399. Inclusion in this directory is not an endorsement.